Skip to content
10-Q

Quarterly Report

ASSERTIO THERAPEUTICS, INC.

0001005201-19-000121

← back to feed
Filed
Nov 7, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Nov 4, 2019 80.68M sh
Shares Diluted Q3 2019 · Sep 30, 2019 72.75M sh
Shares Diluted Q3 2019 · Sep 30, 2019 67.33M sh
Shares Diluted Q3 2019 · Sep 30, 2018 82.69M sh
Shares Diluted Q3 2019 · Sep 30, 2018 82.28M sh
Capex Q3 2019 · Sep 30, 2019 $1.53M
Capex Q3 2019 · Sep 30, 2018 $3.99M
Operating Cash Flow Q3 2019 · Sep 30, 2019 $82.62M
Operating Cash Flow Q3 2019 · Sep 30, 2018 $56.74M
Cash And Equivalents Q3 2019 · Sep 30, 2019 $54.18M
Cash And Equivalents Q3 2019 · Dec 31, 2018 $110.95M
Stockholders Equity Q3 2019 · Sep 30, 2019 $248.43M
Stockholders Equity Q3 2019 · Jun 30, 2019 $197.44M
Stockholders Equity Q3 2019 · Mar 31, 2019 $208.55M
Stockholders Equity Q3 2019 · Dec 31, 2018 $220.34M
Stockholders Equity Q3 2019 · Sep 30, 2018 $242.41M
Stockholders Equity Q3 2019 · Jun 30, 2018 $191.21M
Stockholders Equity Q3 2019 · Mar 31, 2018 $206.09M
Stockholders Equity Q3 2019 · Dec 31, 2017 $169.51M
Current Liabilities Q3 2019 · Sep 30, 2019 $205.73M
Current Liabilities Q3 2019 · Dec 31, 2018 $246.04M
Total Liabilities Q3 2019 · Sep 30, 2019 $508.43M
Total Liabilities Q3 2019 · Dec 31, 2018 $712.53M
Current Assets Q3 2019 · Sep 30, 2019 $124.4M
Current Assets Q3 2019 · Dec 31, 2018 $208.11M
Total Assets Q3 2019 · Sep 30, 2019 $756.87M
Total Assets Q3 2019 · Dec 31, 2018 $932.87M
Eps Diluted Q3 2019 · Sep 30, 2019 $0.05
Eps Diluted Q3 2019 · Sep 30, 2019 −$0.36
Eps Diluted Q3 2019 · Sep 30, 2018 $0.65
Eps Diluted Q3 2019 · Sep 30, 2018 $0.93
Eps Basic Q3 2019 · Sep 30, 2019 $0.05
Eps Basic Q3 2019 · Sep 30, 2019 −$0.36
Eps Basic Q3 2019 · Sep 30, 2018 $0.76
Eps Basic Q3 2019 · Sep 30, 2018 $0.96
Sga Expense Q3 2019 · Sep 30, 2019 $36.12M
Sga Expense Q3 2019 · Sep 30, 2019 $85.92M
Sga Expense Q3 2019 · Sep 30, 2018 $33.41M
Sga Expense Q3 2019 · Sep 30, 2018 $93.75M
Rd Expense Q3 2019 · Sep 30, 2019 $1.48M
Rd Expense Q3 2019 · Sep 30, 2019 $4.53M
Rd Expense Q3 2019 · Sep 30, 2018 $2.13M
Rd Expense Q3 2019 · Sep 30, 2018 $5.84M
Net Income Q3 2019 · Sep 30, 2019 $3.33M
Net Income Q3 2019 · Sep 30, 2019 −$24.58M
Net Income Q3 2019 · Jun 30, 2019 −$13.61M
Net Income Q3 2019 · Mar 31, 2019 −$14.3M
Net Income Q3 2019 · Sep 30, 2018 $48.27M
Net Income Q3 2019 · Sep 30, 2018 $61.05M
Net Income Q3 2019 · Jun 30, 2018 −$21.05M
Net Income Q3 2019 · Mar 31, 2018 $33.82M
Operating Income Q3 2019 · Sep 30, 2019 −$10.13M
Operating Income Q3 2019 · Sep 30, 2019 −$3.44M
Operating Income Q3 2019 · Sep 30, 2018 $9.63M
Operating Income Q3 2019 · Sep 30, 2018 $56.74M
Revenue Q3 2019 · Sep 30, 2019 $55.15M
Revenue Q3 2019 · Sep 30, 2019 $170.28M
Revenue Q3 2019 · Sep 30, 2018 $77.49M
Revenue Q3 2019 · Sep 30, 2018 $269.17M